Member Info for gjbrandon

Why do you think we are main sponsors :-)

@Modern_Water Mobile Services are delighted to be Sponsors of the #PublicHealth and #Water Conference & #Wastewater Disease Surveillance Summit in Cincinnati, Ohio, USA March 21 - 24 https://wef.org/PublicHealth

Cammy, if you are a Father Ted fan, I would say that is an ecumenical question, and expect a smile. However, having been involved in the capital markets for a few decades a simple rule of thumb is that when markets go down it is a good time to invest more into technologies and companies that will outlast a financial crisis. For instance Amazon was always a good business to invest in no matter whether the financial markets are up or down.

The Fed said it was going to fix inflation by raising interest rates and you would expect that bitcoin would rise, but it has crashed, not because bitcoin is not perceived (no judgement on crypo) to be a hedge against inflation, or that gold would also jump, but there was a drive to US Dollar because bonds went up as the Fed slowed down the printing presses.

My point being that markets are not always rational. If you consider technology for wastewater and drinking water testing for global health will outlast interest rate rises and market crashes and that consumers will always want what is best for their skin, then DeepVerge tech should outlast the current volatility. If not, then this is probably not the share to be invested in.

I note this same comment on ADVFN and while I respectfully understand the frustration of all shareholders, which includes myself with a sizable holding, but demand in 2020 had sales of products and services at £4.4m and 2021 orders exceeded £10m and unaudited shipped by the 31st of December was £9.4m. New products and services are being brought online as described in recent RNS based on demand from the mainstream market through existing and new sales, marketing and distribution channels.

Contrary to what some assume the Company has no control on the share price, nor should it. Information is provided that complies to AIM Rule 10, 11 and MAR Article 10.

The share proce is in the hands of existing, new shareholders and sentiment in the market.

SKY News Report today, running all day, has had an amazing response up and down the UK. I get daily articles from monitoring service (not Google) on every publication reference about DeepVerge and so far, on the back of the News Report there have been 25 articles published and discussed on local radio stations.

Article
https://news.sky.com/story/covid-19-technology-developed-to-track-spread-of-coronavirus-could-be-abused-privacy-campaigner-warns-12516018

Video
https://vimeo.com/666444931

Proud of the Modern Water Team

Did you see the size of the device?

That is still not the smallest the mass-produced Microtox PD and BT units will be.

173,334 unlisted warrants, with an exercise price of 15 pence expires January 2023
1.9m unlisted warrants with an exercise price of 25.8 pence per ordinary share and an exercise period until 15 September 2024
Information available https://www.deepverge.com/investors/ under shareholder information tab

@Nthoftheriver. Good place to clarify is RNS.

Skin Trust Club now has over 30,000 registered consumer users.

o 58% of the 30,000+ Skin Trust Club members have underlying skin conditions.

o Home Test processing capacity heading into 2022 is 20,000 per month in each of the UK, Ireland and US laboratories.

o Skin Trust Club members have begun to purchase skincare products, recommended for their personalised daily skincare routines, through a new Skin Trust Club marketplace service. This new in-app and web-based sales channel promotes skin care manufacturers, Labskin partners and consumer test clients, generating wholesale revenue for Labskin on products sold through this platform.

The big ones are coming, but in the meantime, the growth is solid as a rock

@HelloSanDiego while you are waiting for the one big one, the company wioll continue to expand in triple digit percentage growth and that will happen regardless of when "one big contract" happens.

@LTBeliever I am expecting it to be released some time today

@Paulcon2021, The best I can do is the Proactive Interview which I completed earlier and will be released this morning with Katie Pilbeam asking the questions.

@Paulcon2021 again posted elsewhere. The outlook is extremely positive for 2022 and while we are not issuing guidance this early in the year, the Broker Note is what the market expects. If the numbers are outside of what we believe to be unrealistic we would be obliged to make an announcement accordingly. Our orders were in excess of the Broker Note revenue numbers for 2021, just that we could only book the £750k to India and £480k on the Government infrastructure trial in this quarter (beyond year-end)

@HelloSantiago. I repeat what I posted elsewhere. The "one big contract" was the original downfall of every COVID share and even Modern Water before being acquired by DeepVerge. That is not how a solid business creates wealth. It is the multiple revenue streams, from multiple sources, which includes B2C (Consumer) B2B (Business) and B2G (Government) all of which are clients of the divisions within DeepVerge Group. Preferably recurring revenues, like reagents for an increase in monitoring equipment installation, like the ones gone into Beijing ahead of the Winter Olympics, the products sold via the Skin Trust Marketplace, the new Skin Trust Medical video consultations with GP's and derma physicians and of course mobile monitoring services in COVID and other pathogen detection units much like DynoRod franchise opportunities as we roll out mass production.

@Russellba "still making losses despite large revenue"

The projected losses in the trading note are £3m from a full year of depreciation and amortisation post-Modern Water acquisition and are not a cash drain at all. In fact EBITDA loss dropped from a loss of £867k to an expected £220k loss for the entire year.

This tweet and its content might be useful on the heritage of Modern Water Microtox and the Olympics https://twitter.com/gjbrandon/status/1479067240079241221?s=20

@Hello: Some background to some points raised might be helpful with the reference to apples and pears comparison.

When the Modern Water business model hit a critical inflexion point and failed completely in early 2020, pretty much all the membrane tech side of the business was closed down. Some of it prior to being taken over by DeepVerge had to be liquidated and losses for the last year were catastrophic, so the injection of funds, change of Board and change of business model to focus on growth in monitoring has been the key to turning this division around. This is now a much greater proportion of revenues, which did not exist before DV took over. In fact monitoring reagents was closer to $1m annually and monitoring equipment was also in that ball-park.

The more important issue has to do with margin and not just revenues. The key factor longer-term shareholders should consider is how much EBITDA has improved on the increase in revenues. So long as the Company is in line with meeting market expectations, all is good.

I posted this on another Board in response to sill speculation. There is not a single product or service in any division of DeepVerge that relies upon one single government to deliver on our growth trajectory. There is no binary decision of one government, company or collaboration partner that will do anything to slow the rate of growth of the Group. This has been evident from the Company turnover £278k at the end of 2018 to guiding £10m in a little more than 3 years since management took over. You don't have to speculate, just do the math.

My additional comment here is that the growth has been achieved on new technology that did not exist before 2018. Granted Microtox has been around since 1984,but the upgrades to the equipment in Modern Water, over the last 18 months has added analytics and enhanced the revenues for services that did not exist before DeepVerge took over the company in November 2020.

Finally pretty much everything in the Labskin division which includes Skin Trust Club and the soon-to-be-launched STC Medical is 100% innovative and totally unique with a heritage of 15 years of data collected and that is why we can say the match is across 3 revenue sources.

B2B (Business) , B2C (Consumer) and B2G (Government) and that is the foundation of the growth.

My wife has a problem with loose women :-)

Actually, I expect the results of work done with our media partners will be bearing a lot of fruit quite soon on mainstream media. Lots of things happening this monthand with the Omicron restrictions lifted we can get back to keeping the pace of growth going into 2022

In reality, DeepVerge posts less on it's corporate social media channels than Microsaic. It only appears that there is more because I am an active (and have been since 2009) social media user.

Just a point on reputation. Influencers, who really are important, must be satisfied that it works, otherwise, how would they be able to stand over their offering (and I know many who take the payment and do whatever is required. That is clearly not the trust we are seeking). Take the same point with anyone looking to use Skin Trust Club for the first time. It is a trust issue. Influencers need to be informed and with respect, even box openings it is possible to make mistakes. Someone mentioned in a conversation that you can't account for stupid. So, if you are seeking to have an influencer, they can't look stupid either.

It's all a learning curve for everyone and once trust is built, then the value of the influencers become far in excess of being seen by hundreds of thousands of followers, that you made mistakes and screwed up the opening of the box. It isa too important to screw up.